Contact Us

We would love to hear your story. 


Contact Us:

Toll Free: (877) 492-3030

Phone: (501) 372-0038

Fax: (501) 376-9347


The Law Office of David H. Williams

211 S Spring St., 2nd Floor

Little Rock, AR 72201

The Law Office of David H. Williams


211 S Spring St., 2nd Floor
Little Rock, AR 72201

(501) 372-0038

Mass Torts


David Williams

Presently, Abilify lawsuits filed against Bristol-Myers Squibb and Otsuka allege that the uncontrollable, compulsive behaviors were known prior to the 2016 label change. One lawsuit filed on July 25, 2016, in the United States District Court for the District of Massachusetts, states that the European Medicines Agency required Otsuka to warn patients and the medical community in Europe that the use of Abilify includes the risk of pathological gambling. Also, the European label includes additional language under the “Undesirable effects” section stating “Psychiatric disorders: agitation, nervousness, pathological gambling, suicide attempt, suicidal ideation and completed suicide.”

If you or a loved one has taken Abilify and struggled with uncontrollable behavior like compulsive gambling and binge eating or if you have amassed a gambling debt due to an uncontrollable urge to gamble, you may have the option to participate in a lawsuit against Bristol-Myers Squibb and Otsuka Pharmaceutical Company. Contact us today to learn more about your legal rights. There is never a fee unless we collect for you.


David Williams

This session of the Arkansas Legislature has resulted in some of the most dangerous legislation to Arkansans in history.  Yes, I said that: in the history of this State. It is the product of high paid lobbyists who work for Michael Morton, the nursing home owner from Fort Smith who is linked to the bribery of Judge Michael Maggio for reducing a jury’s verdict in return for campaign donations, the State Chamber of Commerce, along with WalMart, Tyson, and a host of special fat cat corporate interests.

The legislation is sometimes bizarre, but most often mean-spirited and greedy. Examples of these bills are one to remove any requirements for any profession or occupation to have a license or certification or training, so that anyone can be a brain surgeon, an electrician, a contractor, an optometrist, as long as they don’t “advertise” that they are one; a bill to create a private cause of action against private and governmental whistleblowers who report fraud and misuse of taxpayer dollars; a bill to exempt nursing homes from safety requirements; a bill to hide the records of city, state and county government actions. And one of the bizarre bills is one that makes is a criminal offense to request any kind of “assistance” after dark. What does that mean? Your 17-year-old daughter has a flat at night on the highway and she can be arrested for “loitering” if she asks for help?

The most egregious, however, is Senate Joint Resolution 8 (SJR8) by Missy Irvin of Mountain Home, and Trent Garner of El Dorado, also sponsored by House Representative Bob Ballinger of Hindsville.  It changes the 1876 Arkansas Constitution section which preserves the right to a jury trial, which is described in our Constitution as an “inviolate” right by putting (1) a cap on the value of life. Yes, on the value of life. Limited to $500,000. Yours, your spouses’, your children’s, your parents’ lives. (2) It caps damages for those who don’t have jobs. (3)  It destroys the judiciary branch of our government by transferring the authority of the Supreme Court to promulgate rules of law on the trial of cases, to the Legislature, which then can create its own rules. (4) It destroys your access to justice by capping what average people can pay a lawyer to represent them when they are hurt or they die as a result of someone else’s negligence.  It does not limit what Walmart or Tyson, or Michael Morton can pay its lawyers to represent them when they hurt or kill someone through their negligence. There is no limit there. So, they can pay their lawyers any amount of money to defeat righteous claims, while you get to fight back with one hand tied behind your back, if you can find a lawyer to fight for you at all.

It is nothing more than basic socialism when the gains are privatized, and the losses are socialized, because the insurance companies will receive the financial benefit for not being held accountable for their wrongs, and the damages, medical care, loss of jobs and the income of the citizens who are injured or killed are foisted on the society and us as taxpayers to absorb through Medicaid, free care for those who have no insurance, and then those costs are passed on to the rest of us.

In other words, we subsidize the bad actors. We subsidize the irresponsible, undesirable companies who come into this State because they’ve found out that the Legislature has opened up our borders by lowering the price for bad actors to pay. If a company can calculate the cost-benefit ratio of killing someone because of a defective product or defective and negligent action, as opposed to the cost of fixing the defect or the negligent action, then it will go to the bottom line every time. And, if it costs less to kill people, and SJR8 caps that cost at $500,000, then they will do that instead of fixing the problem. And, just keep on killing people.

So, stop this craziness and madness. Vote NO to SJR8 in November of 2018.  Tell Senators Missy Irvine and Trent Garner,  and Rep Bob Ballinger that you are going to hold them responsible for this, and that they will NOT be reelected, and tell the other sponsors and legislators who voted for this horribly wrong Amendment to our Arkansas Constitution that they are not going to go back to the Arkansas Legislature and continue to represent our interests, because they do not.


David Williams

Tell Everyone You Know to Vote AGAINST Issue 4 in Arkansas

Help us get the word out! Tell your friends and family. Grab these images to post on Facebook and Instagram.

Browse these files and download as many as you wish. Then send, send, send them out on a regular basis until the vote on November 8. We must work to protect ourselves, our families, and our rights!

CONSUMER ALERTS - Ignition Switch Failures Can Result in Serious Injuries

David Williams

General Motors has recalled over 2.6 million vehicles due to defective and dangerous ignition switches. Following a “jarring event” or use of a heavy key ring, the ignition switch may slip out of the "run" position, shutting down the engine, power steering and the braking system. This loss of power may cause drivers to lose control of their vehicle and, if the car crashes, the airbags to fail to deploy. The results may be fatal.

The ignition switch defect was discovered by GM a decade before the 2014 product recalls were issued. In 2005, GM engineers considered resolving this problem but decided any solution to make the switches safer would be too costly. The National Highway Traffic Safety Administration fined GM $35 million for failing to disclose the problem, and the U.S. Justice Department is investigating the case for possible criminal charges.

The recalls are sweeping, including 2005-10 Chevrolet Cobalt, 2006-10 Pontiac Solstice, 2007-10 Pontiac G5 and Saturn Sky, 2006-11 Chevrolet HHR and 2003-7 Saturn Ion, 2000-2005 Chevrolet Impala and Monte Carlo, 1997-2005 Chevrolet Malibu, 1999-2004 Oldsmobile Alero, 1998-2002 Oldsmobile Intrigue, 1999-2005 Pontiac Grand Am and 2004-2008 Pontiac Grand Prix. All have the same ignition switches.

We are now pursuing civil suits against GM for the injuries and deaths resulting from accidents where the car has “turned off.” If you believe you or a loved one have had an accident as a result of a faulty ignition switch of a GM vehicle, please contact us to discuss your options.

CONSUMER ALERTS - Massive Airbag Recall – Failure Associated with Serious Injury and Death

David Williams

Over 17 million vehicles sold in the United States with airbags manufactured by the Japanese entity Takata have been recalled. The defective airbags have been placed in a wide range of manufacturers’ vehicles including BMW, Ford, GM, Honda, Mazda, Mitsubishi, Nissan, Subaru and Toyota. Reports have indicated that Takata may have been aware of the defect in its airbags as early as 2004.

As of Spring 2015, nearly 90% of the vehicles with defective airbags remain unrepaired. The National Highway Traffic Safety Administration (NHTSA) has urged consumers with an affected vehicle to take action quickly to have their airbag replaced and to reduce the risk of serious injury or death. If you are uncertain whether your vehicle has a defective airbag, you can find out by entering your vehicle’s VIN in the “Search for Recalls” section of the U.S. government website

In affected vehicles, the inflator and propellant devices in the airbag may deploy improperly in the event of a crash. As a result, crash vehicle occupants do not receive the protection from crash forces that they should and, even worse, may be subjected to a shrapnel-like discharge from the airbag. To date, there have been hundreds of injuries reported as a result of these defective airbags including several alleged deaths.

If you or a loved one has a vehicle with a recalled airbag and have been seriously injured by the failure of that airbag, give us a call today for more information.

{Power Morcellator} Hysterectomy or Fibroid Removal Tools Can Increase Risk of Cancer

David Williams

Power morcellators are cutting tools used in minimally invasive laparoscopic hysterectomy and myomectomies (procedures to remove fibroids) to remove the uterus or fibroids through a small incision. Unfortunately, the use of power morcellators creates a serious health risk for women with undetected uterine cancer. When used in women with undetected uterine cancer, the morcellator, which acts similar to a hand blender, essentially distributes cancer cells throughout the pelvis – potentially accelerating the growth of the cancer and/or seeding it in different areas of the body. The FDA has estimated that as many as 1 in 350 women undergoing a hysterectomy or myomectomy may have undetected uterine cancer.

In April 2014, the FDA issued a warning that the use of power morcellators may spread cancer throughout a woman’s body before doctors are aware of a malignancy. As a result, Johnson & Johnson has halted sales of these surgical tools, only after they were used in thousands of procedures.

If you or a loved one had a hysterectomy, fibroid removal or other surgical procedure where a power morcellator was used and were subsequently diagnosed with cancer including uterine sarcoma, leiomyosarcoma, or other cancers, you may be entitled to significant financial compensation. Attorneys are leading the fight against the manufacturers of these surgical tools on behalf of women nationwide. Contact us today to learn more about your legal options.

TIGERPAW® System II Recall Litigation

David Williams

The FDA issued a Class 1 recall on April 23, 2015 on theTigerPawII left atrial appendage (LAA) closure device used during open heart surgery to mitigate post-operative stroke in patients with atrial fibrillation. The recall was issued following reports the device could cause tearing of the left atrial wall along with bleeding events and possible death.

Currently, 4,154 TigerPaw II® devices - made by US- based LAAx (Livermore, CA) and sold by Maquet Medical Systems (Wayne, NJ) between April 1, 2013 and March 23, 2015 - have been recalled.

If you or a loved one had surgery where a TigerPaw System II® was used, please contact us today.

{Transvaginal Mesh}

David Williams

The litigation over defective mesh products sold to women to treat pelvic organ prolapse (POP) and/or stress urinary incontinence (SUI) is among the largest in the history of pharmaceutical and medical device cases. More than 80,000 lawsuits have been filed in courts around the country.

Lawyers are the leaders in the fight for women around the country suffering from the adverse effects of the defective mesh products. Attorney’s have reached agreement in principle to settle claims for women implanted with defective mesh manufactured by the following entities:               

Endo Pharmaceuticals (f/k/a American Medical Systems)

Coloplast • GMD

Attorneys are in active settlement negotiations with the remaining mesh manufacturers, but will continue to press forward with litigation until settlement is reached.)

If you or a loved one has been implanted with a pelvic mesh product and have experienced any adverse effects – pain, pain with intercourse, bleeding, new urinary dysfunction, erosion, surgery to remove the mesh, or anything else – the time to make a claim is now. There are limited time frames in which to participate in the settlements referenced above and limited time to file a lawsuit and preserve your right to participate in a settlement for the remaining manufacturers.

Contact us if you believe you have been injured as a result of a transvaginal mesh implant, even if you have not yet had a revision/removal surgery.

Medications Taken During Pregnancy May Cause Birth Defects

David Williams

{ Zoloft, Effexor, Prozac, Paxil, Topamax, Celexa, Lexapro and Zofran }

Most prescription medications are clearly labeled to indicate whether they may be used safely by pregnant women. Unfortunately, that is not always the case.  attorneys have been the leaders in the fight for families who have children born with defects caused by a prescription medication that was not properly labeled. Improperly labeled drugs that have been linked to birth defects include:

Zofran® - This anti-nausea medication manufactured by GlaxoSmithKline has been prescribed to millions of women suffering the effects of morning sickness. While not approved for morning sickness, the label indicates that it is safe for use by pregnant women. Studies have indicated that is not the case, however, linking Zofran® with cardiovascular deformities and cleft palate.

Zoloft®, Effexor® Prozac®, Paxil®, and Celexa® / Lexapro®- These antidepressants are part of a class of drugs known as selective serotonin and norepinephrine reuptake inhibitors (SSRI & SNRI). They have been prescribed to millions of women during pregnancy. Multiple studies have shown that these drugs are linked to a potentially increased risk of serious birth defects in babies, ranging from skull defects to cleft lip/palate to life threatening heart defects.

Topamax® and Depakote®- these anti-seizure medications have also been linked to serious birth defects. Topamax® has been linked to cleft lip/palate and Depokote® has been linked to neural tube defects such as spina bifida. Johnson & Johnson, the maker of Topamax®, has recently settled dozens of birth defect claims that were scheduled for trial in Philadelphia state court, which indicates that plaintiffs in those cases can successfully prove that the drug maker should be held liable.

Attorneys are leading the fight for justice for victims of these medications. Both the Zoloft® and Effexor® litigations have been consolidated into a multidistrict litigation (MDL) and transferred to a federal court in Philadelphia, Pennsylvania for further proceedings. The MDL court has appointed two partners (Bryan and Jason Richards) to the Plaintiff’s Steering Committees in the Zoloft® and Effexor® litigations, meaning  will be leading the fight for claimants from around the country. 

If you were taking any of these medications while pregnant, there is a possibility that your child’s birth defect was caused by the drug – even if you stopped taking it once you found out you were pregnant.


{Onglyza} Diabetes Drug Linked to Heart Failure Hospitalizations and Death

David Williams

Also linked to Pancreatic & Thyroid Cancers.

Recently, the U.S. Food and Drug Administration (FDA) announced that it is investigating the link between serious heart failure and deaths associated with the diabetes drug Onglyza®(saxagliptin). A recent study published in the New England Journal of Medicine reported an increased rate of hospitalization for heart failures.  

In April 2014, after reviewing the study results which involved over 16,000 clinical trial patients, the FDA advisory panel voted 14-1 to add information about the increased risk of heart failure to the Onglyza® label. Drugs like Onglyza® have already been associated with other serious injuries including pancreatic cancer and thyroid cancer.

If you or a loved one has been hospitalized for heart failure, or if a loved one has died from heart failure, after taking Onglyza®, please call us today. We are also taking cases involving pancreatic cancer and thyroid cancer in patients taking Onglyza®.

{Viagra®} Viagra® May Cause Deadly Melanoma

David Williams

To treat erectile dysfunction and pulmonary hyper- reported an increased rate of hospitalization for heart tension,doctors have prescribed Pfizer’s Viagra to over 45 million men since it hit the market in 1998. The ubiquitous little blue pill poses a potentially deadly threat to all men who have taken it.

According to a recent study in JAMA Internal Medicine, Viagra® increases the incidence of melanoma, the deadliest of skin cancers. The article found that men who had a history of taking Viagra® were approximately twice as likely to suffer from invasive melanoma.

Melanoma begins in the skin cells that synthesize melanin to pigment in the skin before metastasizing, or spreading, if not diagnosed early. Viagra® inhibits the enzyme PDE5A, increasing melanin production and potentially making melanoma cells more invasive, stimulating the cancer’s development. Melanoma accounts for less than 2% of skin cancer cases but a majority of skin cancer deaths.

Pfizer has not taken any steps to warn the public or its consumers about the association between Viagra® and melanoma. If you or a loved one has developed melanoma after taking Viagra®, call the attorneys today to learn more about your legal rights.

{Hip Replacements} Significant Recoveries for Victims of Failed Hip Replacements

David Williams

There are claims on behalf of individuals with failed hip implants manufactured by Stryker (Reju- venate® and ABG II®), DePuy (ASRTMand Pinnacle®), and Wright (Conserve® and Profemur®). Some recipients of these hip im- plant systems may have developing problems which have not yet manifested in symptoms. We urge anyone with one of these hip systems to consult with their physician and request a blood test to detect whether they have elevated levels of heavy metals – specifically chromium and cobalt – in their blood (referred to as metallosis). The test is easy and can help detect a problem before greater damage is done.

For individuals with failed Stryker or DePuy hip implant systems, there are immediate settlement opportunities with over two billion dollars having been set aside to compensate victims. If you or a loved one have been implanted with a Stryker, DePuy, or Wright hip system and have experienced any problems including failure and/or metallosis, we urge you to call us today for more information. Settlement opportunities may have limited time frames, so we urge you to act quickly.


{Actos®} Actos® Causes Bladder Cancer

David Williams

$2.4 Billion Dollar Actos® Settlement Follows Win in Bladder Cancer Trial - 7th Largest Verdict in History

Approximately 9,000 Actos users developed bladder cancer. The settlement has been reported to be one of the largest of its kind in U.S. history - 2.4 billion dollars.                    

The allocation of settlement funds will be determined through a claims administration process with the oversight of a court-appointed Special Master. Each claimant’s allocation will be determined using case-specific factors, such as cumulative dosage and smoking history, along with the extent of injury.

The settlement was reached after attorneys helped try a case on behalf of Actos user Terence Allen which resulted in the seventh largest verdict in U.S. history. That verdict, in excess of nine billion dollars, has since been reduced by the trial court to a little over thirty-seven million and is currently on appeal.       

Lawyers assisted in trying the case and played key roles in the build up to the case. Mr. Overholtz cross-examined key trial witnesses Dr. Mondira Bhattacharya, Takeda’s head of US Drug Safety, and Dr. Meng Tan, Eli Lilly’s Medical Director. Attorneys also took a majority of the pre-trial depositions of the witnesses in the case.             

Individuals who developed bladder cancer following their use of Actos may have a very valuable legal claim. It is critical that such individuals act quickly and have top-quality legal advice to maximize the value of their claims. If you or a loved one developed bladder cancer following the use of Actos, we urge you to give us a call today.

{Incretin Mimetics} Byetta®, Januvia® and Victoza® Linked to Pancreatitis and Pancreatic Cancer

David Williams

Diabetes drugs in the class known as incretin mimetics, including Byetta®, Januvia® and Victoza®, have been linked to cases of severe pancreatitis, and more recently cases of pancreatic cancer.  Unfortunately, pancreatic cancer has one of the highest cancer mortality rates.                 

Lawsuits for Byetta®, Januvia® and/or Victoza® users suffering from severe pancreatitis and/or pancreatic cancer have been consolidated for pretrial purposes before a federal district court in San Diego, California.

Over the past several months, the firm’s attorneys have been busy taking depositions of corporate executives, regulatory employees, and scientists of the drug man-ufacturers. Merck and the other manufacturers are attempting to hide behind the FDA, and downplay the clear warning signal they received about how these drugs can cause and promote this deadly cancer. Our firm is committed to holding them responsible and accountable for putting profits ahead of safety, and harming our clients in the process.                 

If you or a loved one developed pancreatic cancer and ingested any of the incretin mimetic drugs, Byetta®, Januvia® or Victoza®, our firm can help. Please call us today for more information about your potentially valuable legal claim.

{Risperdal®} Jury Awards $2.5 Million In First Risperdal® Trial

David Williams

Risperdal® is an “atypical antipsychotic” medication indicated for the treatment of autism, bipolar disease and schizophrenia. Its manufacturer, Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, marketed Risperdal® to treat children for unapproved uses including the treatment of mood, sleep and attention deficit disorders. As a result of their off-label promotion, Johnson & Johnson has been forced to pay $2.2 billion in fines to state and federal agencies.

Unfortunately, for the adolescent male children prescribed Risperdal®, the drug can cause the pituitary gland to increase its production of prolactin. Prolactin causes the development of breasts. For male children, the development of breasts (known as gynecomastia) can be devastating physically and psychologically. Unfortunately, the condition is permanent with many having to resort to surgery as the only means of correction. Mild cases may be resolved by using a liposuction procedure, while more severe cases require a full mastectomy.

In 2015, two cases brought on behalf of boys who developed gynecomastia after ingesting Risperdal® have been tried. In the first case, tried in Phila- delphia, the jury awarded the plaintiff 2.5 million dollars. In the second, the jury found Johnson & Johnson failed to adequately warn about the risks of gynecomastia, but determined the failure did not cause the plaintiff to be injured. Additional trials are scheduled for later this year.  If you took Risperdal® as a child, or have a male child who took Risperdal®, and subsequently developed breasts or were diagnosed with gynecomastia, you may have a valuable legal claim. Call our attorneys today for more information about your legal rights.

{Benicar®} Blood Pressure Medication Benicar® Linked to Gastrointestinal Injury

David Williams

In 2013, the FDA required Daiichi Sankyo, the manufacturer of Benicar , to update its label to reflect the risk of users developing sprue-like enteropathy. This gastrointestinal disorder, caused by the death of the villi in the small intestine, mimics Celiac disease and leads to symptoms which include severe, chronic diarrhea leading to substantial weight loss, hospitalizations or even death.              

Daiichi Sankyo spent nearly one billion dollars promoting Benicar®, asserting that it was superior to other drugs in its class. However, according to several studies, none of the other angiotensin receptor blocker (ARB) drugs cause the severe injuries associated with Benicar®.

If you or a loved one ingested Benicar®, Benicar HCT®, Tribenzor® or Azor® and developed chronic diarrhea or chronic vomiting that required medical care while ingesting the medicine, you may have a valuable legal claim. Give us a call today.           

{Xarelto®} Anticoagulant Xarelto® May Increase Risk of Stroke, Blood Clots and Internal Bleeding

David Williams

Xarelto® (rivaroxaban) is a newer prescription anticoagulant, or blood thinner, marketed by Bayer and Johnson & Johnson. Xarelto® received FDA approval in 2011 to reduce the risk of strokes, blood clots, deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone hip or knee replacement surgery.

Xarelto® is one of several drugs in a new class of anticoagulants (blood thinners) called direct factor Xa inhibitors. The first of these new class of drugs to gain FDA approval was Pradaxa®. The manufacturer of Pradaxa®, Boehringer Ingelheim, recently settled the lawsuits it was facing, agreeing to pay $650 million to approximately 4,000 people across the United States for similar bleeding injuries.

Xarelto® is like other blood thinners, in that it carries the risk of internal bleeding side effects. However, the internal bleeding caused by Xarelto®cannot be controlled or reversed by physicians, unlike the traditional class of blood thinners which include Coumadin® (warfarin). The Institute for Safe Medication Practices (ISMP) advises that Xarelto® has been associated with “serious, disabling or fatal injury,” including blood clots or thrombolytic events.                

After filing one of the first Xarelto®cases in the country, senior partner Neil Overholtz was appointed by the federal judge overseeing all cases nationwide to the Plaintiff's Steering Committee. Mr. Overholtz was one of only 12 lawyers selected out of nearly 100 applicants nationwide. Mr. Overholtz has also been chosen to lead the discovery effort on behalf of Plaintiffs, as co-chair of the Plaintiff's Discovery Committee. That committee will focus its efforts on document investigation and depositions of corporate witnesses here in the US and in Europe where the drug was developed and tested.              

If you or a loved one suffered a harmful side effect such as a stroke, blood clot, or internal bleeding while taking Xarelto®, you may have a valuable legal claim. Contact us today to speak with one of the attorneys on the forefront of Xarelto® litigation.

{Talc} Household Staple Talcum Powder May Cause Ovarian Cancer

David Williams

We tend to think of talcum powder, composed of magnesium, silicon, and oxygen, as a common and safe household item used to prevent dryness and rashes in a variety of applications. Common household products containing talcum powder include baby powder, facial powders, and adult body powders. Unfortunately, studies have now revealed that there is an association between women who use talcum powder on a regular basis in their pelvic area and the potential development of ovarian cancer.  Studies have reported as high as a 30% increase in the risk of developing ovarian cancer for women exposed to talcum powder on a regular basis. As a result, the International Agency for Research on Cancer (IARC) has classified the perineal (genital) use of talcum-based body powders as “possibly carcinogenic to humans.” Because talcum powder is found in products such as condoms, diaphragms and sanitary napkins, there is a significant risk of talcum powder coming into contact with the ovaries.

If you or a family member has developed ovarian cancer after prolonged use of talcum-based body powders, you may have a valuable legal claim. Contact us today to speak with one of our attorneys about this issue.

{Fluoroquinolones} Levaquin® and Avelox® Antibiotics Linked to Peripheral Neuropathy

David Williams

The FDA has issued a drug safety alert requiring the manufacturer of antibiotics such as Levaquin (levofloxacin) and Avelox (moxi-floxacin) to revise the labeling to warn patients of the risk of permanent nerve damage, called peripheral neuropathy. Fluoroquinolones (FLQs) are a class of popular and highly potent antibiotics that are routinely used to treat relatively minor infections such as sinusitis, urinary tract infections, and sore throats. Levaquin® and Avelox® are the largest brand name drugs in this class. Symptoms of neuropathy include pain, burning, tingling, numbness and/or weakness or increased sensitivity to touch, pain, heat and cold.                   

In August 2013, the FDA required new labeling to reflect that peripheral neuropathy may occur rapidly and potentially be permanent. The FDA’s investigation was prompted by continuing inquiries from Congress and consumer complaints describing prolonged, disabling neuropathy following FLQ use. The FDA’s review found that the onset of peripheral neuropathy after FLQ use can be rapid, often within a few days. It can also be permanent, with 40% experiencing peripheral neuropathy for a year or more. The FDA says the risk of peripheral neuropathy occurs with FLQ’s taken by mouth or by injection.

In a May 2014 letter to the U.S. Senate, Dr. Jay S. Cohen said that “In my 40+ years in pharmacovigilance, FLQ’s surpass Vioxx® and Thalidomide in the degree of permanent harm done.” Fluoroquinolone drugs include:                  

• levofloxacin (Levaquin®) • ciprofloxacin (Cipro®) • moxifloxacin (Avelox®) • norfloxacin (Noroxin®) • ofloxacin (Floxin®) • gemifloxacin (Factive®)           

The attorneys of DHWLAW are actively pursuing claims against the FLQ manufacturers. If you or a loved one has been diagnosed with peripheral neuropathy or has suffered serious nerve damage following the use of Levaquin®, Avelox® or Cipro®, call the lawyers of DHWLAW immediately to discuss your legal rights.